# Edarbi · 40 mg · Tabletki · 30 tabl.



## Poland

- **URPL** — [pl.dose-10060.org](https://pl.dose-10060.org)

## Codes

- **rpl-pack-id** — `88813`
- **eu-number** — `EU/1/11/734/014`

## Status

- **read** — 2026-11-15T02:02:49Z

## Holder

- Takeda Pharma A/S

## Proof

Record pl:presentation:88813 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Edarbi 40 mg](https://dosidal.ai/pack/be/424532-01) — BE — same product (EU central number)
- [EDARBI](https://dosidal.ai/pack/cz/0193425) — CZ — same product (EU central number)
- [Edarbi](https://dosidal.ai/pack/eu/EU-1-11-734-014) — EU — same product (EU central number)
- [EDARBI 40 MG TABLETTA](https://dosidal.ai/pack/hu/210665171) — HU — same product (EU central number)
- [Edarbi 40 mg tablety](https://dosidal.ai/pack/sk/2407A) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
